Mind Medicine (MindMed) Inc., a late-stage clinical biopharmaceutical company, has announced new compensation terms for five recently hired non-executive employees. The agreement includes inducement grants comprising options to purchase a total of 425,450 common shares and 34,500 performance share units (PSUs). The options come with an exercise price set at the closing price on the grant date and will vest over four years, with 25% vesting after the first year and the rest vesting monthly over the following three years. The PSUs are set to vest on the third anniversary of their respective grant dates, contingent on performance metrics, and could result in 0%-200% of the target number of PSUs being earned, depending on the achievement of specific performance criteria.